In silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens.

Conclusion: Based on our in-silico analyses, the proposed vaccine may be considered for the immunotherapy of TNBC. PMID: 30788259 [PubMed]
Source: BioImpacts - Category: Research Tags: Bioimpacts Source Type: research